Evidence-Based Complementary and Alternative MedicineVolume 2011 (2011), Article ID 249487, 13 pagesdoi:10.1093/ecam/nep060

Original Article

Gastroprotective Effect of Ginger Rhizome (Zingiber officinale) Extract: Role of Gallic Acid and Cinnamic Acid in H⁺, K⁺-ATPase/H. pylori Inhibition and Anti-Oxidative Mechanism

Siddaraju M. Nanjundaiah, Harish Nayaka Mysore Annaiah, and Shylaja M. Dharmesh

Department of Biochemistry and Nutrition, Central Food Technological Research Institute, CSIR, Mysore 570 020, Karnataka, India

Received 28 November 2008; Accepted 28 May 2009

Copyright © 2011 Siddaraju M. Nanjundaiah et al. Siddaraju M. Nanjundaiah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Zinger officinale has been used as a traditional source against gastric disturbances from time immemorial. The ulcer-preventive properties of aqueous extract of ginger rhizome (GRAE) belonging to the family Zingiberaceae is reported in the present study. GRAE at 200 mg kg⁻¹ b.w. protected up to 86% and 77% for the swim stress-/ethanol stress-induced ulcers with an ulcer index (UI) of 50 ± 4.0/46 ± 4.0, respectively, similar to that of lansoprazole (80%) at 30 mg kg⁻¹ b.w. Increased H⁺, K⁺-ATPase activity and thiobarbituric acid reactive substances (TBARS) were observed in ulcer-induced rats, while GRAE fed rats showed normalized levels and GRAE also normalized depleted/amplified anti-oxidant enzymes in swim stress and ethanol stress-induced animals. Gastric mucin damage was recovered up to 77% and 74% in swim stress and ethanol stress, respectively after GRAE treatment. GRAE also inhibited the growth of H. pylori with MIC of 300 ± 38 μg and also possessed reducing power, free radical scavenging ability with an IC₅₀ of 6.8 ± 0.4 μg mL⁻¹ gallic acid equivalent (GAE). DNA protection up to 90% at 0.4 μg was also observed. Toxicity studies indicated no lethal effects in rats fed up to 5 g kg⁻¹ b.w. Compositional analysis favored by determination of the efficacy of individual phenolic acids towards their potential ulcer-preventive ability revealed that between cinnamic (50%) and gallic (46%) phenolic acids, cinnamic acid appear to contribute to better H⁺, K⁺-ATPase and Helicobacter pylori inhibitory activity, while gallic acid contributes significantly to anti-oxidant activity.

1. Introduction

More and more evidences are being accumulated nowadays regarding the cause of gastric hyperacidity and ulcers. Stress appear to play a major role as indicated by a set of studies which emphasizes that any patient irrespective of the nature of the disease, if admitted to emergency wards in the hospital, invariably ends up with gastric ulcers [1].

Besides this there are characteristic problems such as (i) Zollinger-Ellisson syndrome where there is a high and uncontrolled production of acid; (ii) the use of non-steroidal anti-inflammatory drugs [2] (NSAID) for rheumatoid diseases and (iii) a rod-shaped pathogenic bacteria Helicobacter pylori, normally existing in human stomach are known to cause ulcers [3]. Ulceration may occur either by uncontrolled production of acid or by the side effects of NSAIDs which acts as inhibitors of gastric mucosal defense or by manipulating the mucosal epithelium structure-function causing a defenseless condition and hence ulcers. The concept of management of ulcer disease is fast changing. Treatment was based on the principle that excessive secretion of acid is the reason for ulcer symptoms. However, understanding the role of histamine, gastrin and acetylcholine in addition to gastric acid in controlling gastric secretion lead to the designing of anti-ulcer drugs which act as blockers of such receptors. The role of enzymic gastric proton pump with H⁺, K⁺-ATPase activity is very crucial in varieties of ulcers irrespective of the root cause [4]. Therefore, blockers of H⁺, K⁺-ATPase has been considered and explored to design anti-ulcer drugs such as omeprazole, lansoprazole, etc. However, these proton pump blockers are documented to cause lots of side effects [5], especially in the presence of non-steroidal anti-inflammatory drugs, pregnancy, lactation and alcoholic consumption. Current article therefore addresses an alternative source for the potential ulcer cure, addressing the use of common dietary sources for effective prevention or healing of ulcerations (Scheme 1). Further, it is pertinent to address this question because in traditional medicine for which ginger had a high grade; its potency needs to be evaluated in vivo in the form it is used in traditional medicine (aqueous extract of ginger—GRAE).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

Figure 1: Macroscopic observation of Ulcers in ulcer induced/protected stomachs in swim stress-/ethanol stress-induced ulcer models. Ulcer was induced in animals by either swim stress (SS) or ethanol stress (ES) in group of pre-treated/untreated animals at indicated concentrations. In healthy control (a) no ulcer lesions or damage in the stomach tissue was observed. In ethanol stress (b) and swim stress (c) induced animals, ulcers score were very high. Lansoprazole (d, g) and GRAE at 100 and 200 mg kg⁻¹ treated animals showed dose-dependent reduction in stomach lesions (e, f, h, i). (j) Maximum ulcer index observed during stress induction was controlled in a concentration-dependent manner. Reduction in ulcer index and percent protection is depicted.

3.2. Evaluation of GRAE Potential on Oxidant and Anti-Oxidant Status in Ulcerous and Treated Animals

A 2- to 2.4-fold increase in SOD and GPX levels in stomach tissue were observed in swim/ethanol stress-induced animals and were normalized upon treatment with GRAE in a dose-dependent manner. Whereas, CAT and GSH decreased to 1.6-fold during stress-induced ulcerous conditions were normalized upon treatment with GRAE as shown in Tables 1 and 2. Approximately 2.6-fold increase in TBARS levels indicated the lipid peroxidation or damage of stomach tissue in ulcerous animals; and was recovered up to 91% upon treatment with GRAE. A 2- to 2.3-fold increase in TBARS levels observed in serum and liver homogenate of stress-induced ulcerous groups was recovered also up to 75% upon GRAE treatment at 200 mg kg⁻¹ b.w.

Table 1: Anti-oxidant/anti-oxidant enzymes and TBARS levels in swim stress-induced ulcer model () mean ± SD.

Parameters
Protein (mg g⁻¹)
SOD (U mg⁻¹)
Catalase (U mg⁻¹)
Glutathione Peroxidase (nmol g⁻¹)
GSH (U mg⁻¹)
TBARS nmol

Stomach

    Healthy

    Ulcerated

    GRAE 100 mg kg⁻¹

    GRAE 200 mg kg⁻¹

    Lansoprazole

Serum

    Healthy

    Ulcerated

    GRAE 100 mg kg⁻¹

    GRAE 200 mg kg⁻¹

    Lansoprazole

Liver

    Healthy

    Ulcerated

    GRAE 100 mg kg⁻¹

    GRAE 200 mg kg⁻¹

    Lansoprazole

Different letters “a” to “d” in the column represents that values are significantly different when compared between ulcer induced with healthy control and GRAE/lansoprazole-treated groups.

Table 2: Anti-oxidant/anti-oxidant enzymes and TBARS levels in swim ethanol-induced ulcer model () mean ± SD.

Parameters
Protein (mg g⁻¹)
SOD (U mg⁻¹)
Catalase (U mg⁻¹)
Glutathione Peroxidase (nmol g⁻¹)
GSH (U mg⁻¹)
TBARS nmol

Stomach

    Healthy

    Ulcerated

    GRAE 100 mg kg⁻¹

    GRAE 200 mg kg⁻¹

    Lansoprazole

Serum

    Healthy

    Ulcerated

    GRAE 100 mg kg⁻¹

    GRAE 200 mg kg⁻¹

    Lansoprazole

Liver

    Healthy

    Ulcerated

    GRAE 100 mg kg⁻¹

    GRAE 200 mg kg⁻¹

    Lansoprazole

Different letters “a” to “d” in the column represents that values are significantly different when compared between ulcer induced with healthy control and GRAE/lansoprazole-treated groups.

3.3. H⁺, K⁺-ATPase Inhibition and Mucin Protection by GRAE

The elevated levels of H⁺, K⁺-ATPase in swim stress and ethanol stress was normalized upon treatment with GRAE in a dose-dependent manner. Oral pre-treatment of GRAE inhibited the H⁺, K⁺-ATPase activity and showed 3.1- and 2.9-fold reduction at 200 mg kg⁻¹ b.w. In case of lansoprazole, slightly decreased level of H⁺, K⁺-ATPase activity was observed (Table 3) and the results were also validated by in vitro assay—inhibition of H⁺, K⁺-ATPase enzyme from sheep stomach parietal cells. GRAE inhibited H⁺, K⁺-ATPase activity with an IC₅₀ of 16.5 ± 1.2 μg GAE as opposed to that of lansoprazole (19.3 ± 2.2 μg w/w) indicating increased potency of GRAE. Further, the damaged mucin in ulcerous condition was protected up to 68–72% upon treatment with GRAE at 200 mg kg⁻¹ b.w (Table 3).

Table 3: Gastric mucin and H⁺, K⁺-ATPase levels in healthy, ulcerated and protected rats () mean ± SD.

Group ()
Mucin content (mg g⁻¹)
H⁺, K⁺-ATPase μmol Pi released mg⁻¹ h⁻¹

Healthy

Swim stress-induced ulcer model

    Swim stress induced

    GRAE 100 mg kg⁻¹ b.w.

    GRAE 200 mg kg⁻¹ b.w.

    Lansoprazole 30 mg kg⁻¹ b.w.

Ethanol stress-induced ulcer model

    Ethanol stress induced

    GRAE 100 mg kg⁻¹ b.w.

    GRAE 200 mg kg⁻¹ b.w.

    Lansoprazole 30 mg kg⁻¹ b.w.

Different letters “a” to “d” in the column represents that values are significantly different when compared between ulcer induced with healthy control and GRAE/lansoprazole-treated groups. Range was provided by Duncan multiple test at . significant; significant; significant and significant.

3.4. Toxicity Studies with GRAE

Toxicity studies with aqueous solution of GRAE were carried out in rats for safety evaluation indicated no lethal effect upto 1  g kg⁻¹ b.w. when orally fed for 14 days. There were no significant differences in total protein, TBARS levels, SGPT, SGOT and ALP between normal and GRAE-treated rats (Table 4) indicating no adverse effect on the major organs. Animals after above treatment schedule remained healthy as that of control animals with normal food and water intake, body weight gain and behavior.

Table 4: Toxicity studies with GRAE () mean ± SD.

Parameters
Control
GRAE treated

Total protein

SGOT (U mg⁻¹ protein)

SGPT (U mg⁻¹ protein)

ALP (U mg⁻¹ protein)

TBARS (nmol mg⁻¹ protein)

SGPT, Serum glutamate pyruvate transaminase; SGOT, Serum glutamate oxaloacetate transaminase; ALP, Alkaline phosphatase. between control and GRAE-treated groups.

3.5. Anti-Helicobacter pylori Activity of GRAE

The bacteria isolated from endoscopic samples were Gram-negative, motile and showed positive for urease, catalase and oxidase tests (Table 5). Further, it was confirmed by the response to antibiotics as it was resistant to antibiotics like erythromycin, nalidixic acid, polymixin B, penicillin and vancomycin and was susceptible to amoxicillin, clarithriomycin and metronidazole. The appearance of a characteristic white mucilaginous colony confirms the identity of bacteria as H. pylori.

Table 5: Characteristic biochemical tests for H. pylori.

Tests
Results

Urease
+ve

Catalase
+ve

Oxidase
+ve

Gram staining
Gram negative

Motility
Motile

Colony characteristic
White mucilage type

Antibiotics

    Erythromycin
Resistant

    Nalidixic acid
Resistant

    Polymixin
Resistant

    Penicillin
Resistant

    Vancomycin
Resistant

    Amoxicillin
Susceptible

    Clarithromycin
Susceptible

    Metronidazole
Susceptible

Helicobacter pylori obtained from endoscopic excision was subjected to various biochemical tests to confirm the identity of isolated bacteria as H. pylori. Gram staining, enzyme analysis and morphological analysis as well as antibiotic resistance/susceptibility were included in the tests for characterization of H. pylori.

In the agar diffusion method, GRAE showed a clear inhibition zone around the disc at 50 μg mL⁻¹ concentration equivalent to that of a susceptible antibiotic amoxicillin at 10 μg mL⁻¹ (Figure 2(a)). MIC values determined by broth dilution method indicated significant anti-H. pylori activity at 300 ± 38 μg mL⁻¹ at .

Figure 2: Effect of GRAE on H. pylori growth. Anti-H. pylori activity was tested by the standard agar diffusion method (a). A 5.5 mm discs containing 10 μg each of Amoxicillin-a known antibiotic (a.2); GRAE were impregnated with agar and (a.1) served as control with no inhibitor disc. Clear area around the disc represents the inhibition zone due to the effect of the test fraction. (b)–(f) indicate the scanning electron microscopic pictures at 15 k magnification of control (b), amoxicillin (c), GRAE (d) treated H. pylori and (e) and (f) depicts the H. pylori treated with pure phenolic acids gallic and cinnamic acid respectively. Untreated control cultures indicate uniform rod shaped H. pylori cells. Amoxicillin treatment showed coccoid form, blebbing, fragmented and lysed cells. Similar altered conditions observed in GRAE and pure phenolics treated H. pylori cells. were taken from our previous paper [14] for the comparative purpose.

SEM observation revealed the efficacy of GRAE action in inhibiting the H. pylori growth. Figure 2(b) shows the uniform rod-shaped normal H. pylori cells, whereas the cells treated with amoxicillin, GRAE, gallic and cinnamic acid changed from helical form to coccoid and became necrotic (showed with arrows in Figures 2(c)–2(f)). Coccoid form with blebs in the bacterial surface, appearance of vacuoles, granules and an area of low electron density in the cytoplasm (showed with arrow marks) were observed in GRAE-treated sample indicating the lysis of H. pylori. Results were also substantiated by viability test, which indicated the loss of 85% viability upon treatment with GRAE supporting anti-microbial nature of GRAE.

3.6. Multipotent Anti-Oxidant Activity of GRAE

The ginger aqueous extract possessed 7.6 ± 0.5 mg GAE/g phenolics. The HPLC analysis of GRAE revealed that cinnamic acid (50%) and gallic acid (46%) were the major phenolic acids with small amounts of caffeic, ferulic, gentisic, protocatechuic, syringic and vanillic acids (Figure 3). The total reducing power ability of GRAE was 1168 90 U g⁻¹ GAE (Figure 4(a)) and Figures 4(b) and 4(c) illustrates the scavenging effect of GRAE on DPPH radical and inhibition of lipid peroxidation at IC₅₀ 6.8 0.4 μg mL⁻¹ GAE and 16.8 1.2 μg GAE, respectively. GRAE also exhibited DNA protective ability (Figure 5); the damaged DNA migrated fast, while protected DNA moved slowly as that of normal, untreated DNA. Image analysis indicated recovery of DNA up to 90%.

(a)

(b)

Figure 3: HPLC analysis of phenolic acid constituents in GRAE. A 1 mg mL⁻¹ solution of GRAE (a.3) was prepared, after vortexing for 10 min at room temperature with the mobile phase-water/acetic acid/methanol—80 : 5 : 15 (v/v/v)—Isocratic and 20 μL of each was loaded on to HPLC Shimpak C18 column (4.6 250 mm, Shimadzu Corp, Kyoto, Japan). A 20 μL of mg mL⁻¹ standard phenolic acids were loaded independently and their specific retention time (min) was established. Phenolic acids in GRAE were identified comparing with their retention time with known standards.

(a)

(b)

(c)

Figure 4: Anti-oxidant potency of GRAE. Concentration of 5–25 μg GAE/mL of GRAE were examined for reducing power (a), free radical scavenging (b) and inhibition of lipid peroxidation (c) as per the protocol described under materials and methods section. All data are the mean ± SD of three replicates.

Figure 5: DNA protection ability of GRAE. One microgram of native calf thymus DNA in (lane 1); DNA treated with Fenton's reagent (lane 2); DNA pre-treated with 2, 4, 6 μg of GRAE (lanes 3–5) were loaded on to the 1% agarose gel. Bands were visualized by staining with ethidium bromide and in the transilluminator increased mobility represents DNA damage.

3.7. HSA Interaction

Since there was a significant reduction in H⁺, K⁺-ATPase which could be attributed to phenolics⁶, current study attempted to explore the possible binding of phenolics to the enzyme by virtue of phenolic acids. For comparative purpose, two phenolic acids—gallic acid and cinnamic acids that showed poorer and potent H⁺, K⁺-ATPase inhibitory activity respectively, were examined in presence and absence of gallic/cinnamic acids and expressed as Sterner's constant.

Results from HSA interaction studies indicated that the changes occurred in the environment of tryptophan residues in HSA and was dependent on the applied phenolic acids. As shown in Figure 6, both gallic and cinnamic acids showed HSA binding, but to varying extent. K sv of cinnamic and gallic acid were found to be 0.024 10⁶ M⁻¹ and 0.016 × 10⁶ M⁻¹, respectively. Approximately 1.5-fold increase in binding was observed with cinnamic acid than gallic acid. However, 5-fold better H⁺, K⁺-ATPase inhibition with cinnamic acid than gallic acid suggests that parameters other than binding may also influence H⁺, K⁺-ATPase inhibitory activity in case of cinnamic acid. Cinnamic acid being hydrophobic, may access the membrane domain of H⁺, K⁺-ATPase which is lacking in HSA, may possibly accounted for enhanced inhibitory activity.

(a)

(b)

(c)

Figure 6: Fluorescence emission spectra of HSA in the presence of gallic acid and cinnamic acid. The extinction wave length was 280 nm. Both excitation and emission slits widths were 5 nm. Inlaid figure—Stern-Volmer plots (x-axis: concentration in micrograms; y-axis: F ⁰/F).

4. Discussion

Ulcer results from an imbalance between aggressive factors and the maintenance of mucosal integrity through the endogenous defense mechanisms. To regain the balance, different therapeutics including spice and plant extracts have been used. In the previous paper, we had shown that free and bound phenolics of ginger possessed potential ulcer preventive activity in vitro, including inhibition of H⁺, K⁺-ATPase and H. pylori growth [9]. However, in view of addressing a question whether the traditional practice of using crude ginger extract in either boiled water or cold water extract can yield compounds which are gastroprotective in nature; we evaluated in vitro and in vivo ulcer-preventive properties of GRAE and determined whether it also contained phenolic acids that favors gastroprotection as reported in our previous papers [9, 17].

ROS are implicated in the pathogenesis of several diseases. Free radicals are continuously produced during normal physiologic events and removed by anti-oxidant defense mechanisms, including enzymes such as SOD, CAT and enzymes involved in the glutathione redox cycle. Free radicals cause lipid peroxidation and production of highly toxic lipid derivatives, which in turn can modify cell functions and even may lead to cell death. Oxidative modification of proteins may result in structural impairment and also change their functional properties such as their involvement in signaling, critical for numerous cellular functions. They affect the vasomotor function of vasculature throughout the body via alterations in the activity of the autonomic nervous system, thus changing the blood flow to involve tissues such as mucosa. Oxidative stress (OS) being major source in causing ROS-mediated ulceration, up/down regulation of anti-oxidant/anti-oxidative enzymes reveal the ability of GRAE to counteract the OS condition and hence protection to ulcer.

GRAE at 200 mg kg⁻¹ b.w. protected swim stress/ethanol-induced ulcer lesions up to 86% similar to that of lansoprazole (80%), a known antiulcer drug at 30 mg kg⁻¹ b.w. Bloody streaks, inflammations, oozing of blood into the lumen of the stomach, and so forth, observed in ulcerous animals were not found in GRAE ingested animals, similar to those of healthy rats indicating the gastroprotective effect of GRAE. Further, we followed the protective effect investigating the biochemical parameters such as alterations in the gastric mucin, oxidants, GSH, H⁺, K⁺-ATPase and anti-oxidant enzymes level including CAT, SOD, peroxidase, and so forth, in the ulcerated organ—stomach as well in the metabolizing organ—liver in all groups of rats—healthy, ulcerated and GRAE/lansoprazole treated. Preventive anti-oxidant enzymes such as SOD and CAT are the first line of defense against ROS. Administration of GRAE resulted in a significant increase in the SOD, CAT and reduced GSH levels (Tables 1 and 2) similar to those of control animals, suggesting the efficacy of GRAE in preventing free radical-induced damage during ulceration. SOD, GPx, CAT and GSH all contribute to maintain anti-oxidant status during oxidative stress condition such as ulcers. SOD and GPx levels were increased during ulceration to scavenge superoxide and peroxy radicals generated during ulceration. Depletion in CAT and reduced GSH suggest the utilization of these components towards the neutralization of increased free radicals.

In our experimental model, 3.4-fold reduction in gastric mucin and 2.4-fold reduced glutathione as well as 2.6-fold increased oxidative product—TBARS in the stomach were normalized by GRAE (Tables 1–3) treatment. Gastric ulcers are often a chronic disease and it may persist for 10–20 years as characterized by repeated episodes of healing and re-exacerbations [23]. Stress-induced ulcer better resembles clinical ulcers in chronicity, severity and practicality of experiencing stress due to varietal patterns of lifestyle in day to day life and serves the most reliable model to study ulcer healing process [24, 25]. The incidence of swim stress-induced ulcer is predominant in the glandular part of the stomach leading to gastric mucosal/mucin damage. GRAE significantly prevented ulcers both by reducing the oxidative stress as well as boosting the mucosal defense.

Further, during our study, we evaluated the possible mechanism of protection to gastric ulcer apart from up-regulation of anti-oxidant and anti-oxidant enzyme levels. Gastric H⁺, K⁺-ATPase located in the apical membrane of parietal cells, pumps protons into the gastric lumen, using energy derived from the hydrolysis of ATP, and is thus involved in gastric acid secretion. Accordingly, the activity of gastric H⁺, K⁺-ATPase was measured in the stomach homogenate, which showed 3-fold up-regulation of the enzyme in ulcer condition and was normalized by treatment with GRAE (Table 3). Results were further substantiated by sheep H⁺, K⁺-ATPase inhibition by GRAE with an IC₅₀ of 16.5 1.2 μg mL⁻¹ on par or better than lansoprazole (19.3 2.2 μg w/w), indicating the potential multi-targeted effect of GRAE in preventing swim stress-induced ulcers in experimental rats. GRAE may find itself more useful as a H⁺, K⁺-ATPase (proton pump) inhibitor than the existing pump inhibitors, since they have adverse effects as reported particularly under conditions of pregnancy/lactation and alcohol or any other drug consumption. Least toxicity of GRAE may also find GRAE as useful alternative source for ulcer healing therapeutics.

Besides, GRAE also exhibited the anti-H. pylori activity. The MIC values obtained confirmed the significant () anti-H. pylori activity, and as reported in previous papers results were supported by an observation of Vattem et al. [18], where phenolic phytochemicals such as cinnamic acid, cinnamaldehyde, coumarins and flavonoids have been suggested to exhibit high anti-H. pylori activity. GRAE with higher content of cinnamic acid showed better inhibition of H. pylori. As mentioned in earlier studies, phenolics were thought to exert their anti-microbial effect by causing (i) hyperacidification at the plasma membrane interface of the microorganism [26] or (ii) intracellular acidification, resulting in disruption of H⁺, K⁺-ATPase required for ATP synthesis of microbes [27] or (iii) may be related to inactivation of cellular enzymes causing membrane permeability changes [27].

Also, it is intriguing to observe that cinnamic acid is acting as a potent inhibitor of H⁺, K⁺-ATPase, and also H. pylori probably by stronger binding of cinnamic acid to membrane domains of H⁺, K⁺-ATPase and H. pylori than gallic acid, which is a poor inhibitor of H⁺, K⁺-ATPase and H. pylori (Figure 6). Lack of correlation between fold inhibitory activity versus binding between gallic/cinnamic acid still do not rule out the proposed mechanism. Because being hydrophobic cinnamic acid binding ability may be higher with H⁺, K⁺-ATPase and H. pylori which carry membrane domains than HSA alone which is devoid of this hydrophobic domain.

GRAE also exhibited reducing power and prevented free radical-induced lipid and DNA peroxidation. This anti-oxidative property also contributes significantly to reduce ulcer condition and justifies the ethno medical claims. Table 6 shows the relative concentration of individual phenolic acids towards the antiulcer activity. Our data in the present and previous papers indicate that cinnamic acid, caffeic acid and p-coumaric acids contribute significantly to inhibition of H⁺, K⁺-ATPase and H. pylori growth in the free as well as in the bound form. Recently, we also reported the role of cinnamic acid in cross-linking property of pectic polysaccharide and its contribution hence to the structural stability (manuscript communicated).

Table 6: Relative percentage contribution of individual phenolic acids towards anti-oxidant, anti-H. pylori and H⁺, K⁺-ATPase inhibition.

GRAE
Phenolics (mg g⁻¹)
AOX (% contribution)
PPI (% contribution)
H pylori-inhibition (% contribution)

Gallic acid
3.4
93
9
66

Cinnamic acid
3.8
1
88
30

Other phenolics
0.4
6
3
4

Gallic acid significantly contributed to anti-oxidant activity than cinnamic acid where as cinnamic acid contributed to H⁺, K⁺-ATPase inhibition.

5. Conclusions

The present study clearly demonstrated that aqueous extract of ginger was able to protect the gastric mucosa from stress-induced mucosal lesions and inhibits gastric acid secretion probably by blocking H⁺, K⁺-ATPase action, inhibiting growth of H. pylori and offering anti-oxidant protection against oxidative stress-induced gastric damage The results confirm the popular use of ginger for its medicinal properties in Ayurveda and folklore medicines. These results further suggest the use of ginger for gastric disorders that needs to be considered as possibilities for new therapeutic approaches.

Acknowledgments

The authors thank Dr V. Prakash, Director, Central Food Technological Research Institute, Mysore for his keen interest in the work and encouragement. Authors are thankful to Karnataka Cardio Diagnostic Centre; Mysore for providing H. pylori. S. M. D. acknowledges Department of Biotechnology, New Delhi, India for financial assistance. S .M. N. and H. N. M. A. thank Council for Scientific and Industrial Research, India for Senior Research fellowships.

References

W. F. Vorder Bruegge and D. A. Peura, “Stress-related mucosal damage: review of drug therapy,” Journal of Clinical Gastroenterology, vol. 12, no. 2, pp. S35–S40, 1990.

S. C. Lewis, M. J. Langman, J. R. Laporte, J. N. Matthews, M. D. Rawlins, and B. E. Wiholm, “Dose-response relationships between individual non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data,” British Journal of Clinical Pharmacology, vol. 54, pp. 320–326, 2002.

J. H. Kurata and A. N. Nogawa, “Meta-analysis of risks factors for peptic ulcer: nonsteroidal anti-inflammatory drugs, Helicobacter pylori and smoking,” Journal of Clinical Gastroenterology, vol. 24, pp. 2–17, 1997.

G. Sachs, J. G. Spenney, and M. Lewin, “H⁺ transport: regulation and mechanism in gastric mucosa and membrane vesicles,” Physiological Reviews, vol. 58, no. 1, pp. 106–173, 1978.

H. L. Waldum, B. Gustafsson, R. Fossmark, and G. Qvigstad, “Antiulcer drugs and gastric cancer,” Digestive Diseases and Sciences, vol. 50, no. 1, pp. S39–S44, 2005.

M. Yoshikawa, S. Yamaguchi, K. Kunimi, H. Matsuda, Y. Okuno, J. Yamahara, and N. Murakami, “Stomachic principles in ginger. III. An anti-ulcer principle, 6- gingesulfonic acid, and three monoacyldigalactosylglycerols, gingerglycolipids A, B, and C, from Zingiberis Rhizoma originating in Taiwan,” Chemical and Pharmaceutical Bulletin, vol. 42, no. 6, pp. 1226–1230, 1994.

E.-C. Kim, J.-K. Min, T.-Y. Kim, S.-J. Lee, H.-O. Yang, S. Han, Y.-M. Kim, and Y.-G. Kwon, “[6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo,” Biochemical and Biophysical Research Communications, vol. 335, no. 2, pp. 300–308, 2005.

M. A. Al-Yahya, S. Rafatullah, J. S. Mossa, A. M. Ageel, N. S. Parmar, and M. Tariq, “Gastroprotective activity of ginger Zingiber officinale Rosc., in albino rats,” American Journal of Chinese Medicine, vol. 17, no. 1-2, pp. 51–56, 1989.

M. N. Siddaraju and S. M. Dharmesh, “Inhibition of gastric H⁺,K⁺-ATPase and Helicobacter pylori growth by phenolic antioxidants of Zingiber officinale,” Molecular Nutrition and Food Research, vol. 51, no. 3, pp. 324–332, 2007.

P. S. Brady, L. J. Brady, and D. E. Ullrey, “Selenium, vitamin E and the response to swimming stress in the rat,” Journal of Nutrition, vol. 109, no. 6, pp. 1103–1109, 1979.

M. Jainu and C. S. Devi, “Antiulcerogenic and ulcer healing effects of Solanum nigrum (L.) on experimental ulcer models: possible mechanism for the inhibition of acid formation,” Journal of Ethnopharmacology, vol. 4, pp. 56–163, 2006.

B. M. Srikanta, M. N. Siddaraju, and S. M. Dharmesh, “A novel phenol-bound pectic polysaccharide from Decalepis hamiltonii with multi-step ulcer preventive activity,” World Journal of Gastroenterology, vol. 13, no. 39, pp. 5196–5207, 2007.

O. H. Lowry, N. J. Roseburg, A. L. Farr, et al., “Protein measurement with the Folin phenol reagent,” Journal of Biological Chemistry, vol. 193, pp. 265–275, 1951.

D. Das and R. K. Banerjee, “Effect of stress on the antioxidant enzymes and gastric ulceration,” Molecular and Cellular Biochemistry, vol. 125, no. 2, pp. 115–125, 1993.

N. Yougender, J. Smitha, M. A. Harish Nayaka, et al., “Gastroprotective effect of swallow root (Decalepis hamiltonii) extract: possible involvement of H⁺ K⁺-ATPase inhibition and antioxidative mechanism,” Journal of Ethnopharmacology, vol. 112, pp. 173–179, 2007.

S. J. Corne, S. M. Morrissey, and R. J. Woods, “A method for the quantitative estimation of gastric barrier mucus,” Journal of Physiology, vol. 242, no. 2, pp. 116–117, 1974.

M. N. Siddaraju and S. M. Dharmesh, “Inhibition of gastric H⁺,K⁺-ATPase and Helicobacter pylori growth by phenolic antioxidants of Curcuma amada,” Journal of Agricultural and Food Chemistry, vol. 55, no. 18, pp. 7377–7386, 2007.

D. A. Vattem, Y.-T. Lin, R. Ghaedian, and K. Shetty, “Cranberry synergies for dietary management of Helicobacter pylori infections,” Process Biochemistry, vol. 40, no. 5, pp. 1583–1592, 2005.

A. Braca, G. Fico, I. Morelli, F. De Simone, F. Tomè, and N. De Tommasi, “Antioxidant and free radical scavenging activity of flavonol glycosides from different Aconitum species,” Journal of Ethnopharmacology, vol. 86, no. 1, pp. 63–67, 2003.

G. C. Yen and H. Y. Chen, “Antioxidant activity of various tea extracts in relation to their antimutagenecity,” Journal of Agricultural and Food Chemistry, vol. 43, pp. 27–32, 1995.

V. L. Singleton and J. A. Rossi, “Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagent,” American Journal of Enology and Viticulture, vol. 16, pp. 144–158, 1965.

G. S. Kumar, H. Nayaka, S. M. Dharmesh, and P. V. Salimath, “Free and bound phenolic antioxidants in amla (Emblica officinalis) and turmeric (Curcuma longa),” Journal of Food Composition and Analysis, vol. 19, no. 5, pp. 446–452, 2006.

P. A. Bakumov, I. V. Shchepotkin, Y. L. Dugina, O. I. Epstein, and S. A. Sergeeva, “Clinical efficiency of epigam in patients with exacerbation of peptic ulcer disease of the stomach and duodenum,” Bulletin of Experimental Biology and Medicine, vol. 135-136, no. 1, pp. 159–162, 2003.

J. Thomas, M. Greig, and D. W. Piper, “Chronic gastric ulcer and life events,” Gastroenterology, vol. 78, no. 5, pp. 905–911, 1980.

M. P. Jones, “The role of psychosocial factors in peptic ulcer disease: beyond Helicobacter pylori and NSAIDs,” Journal of Psychosomatic Research, vol. 60, no. 4, pp. 407–412, 2006.

R. G. Labbe, “Food-borne pathogens, health and role of dietary phytochemicals,” Asia Pacific Journal of Clinical Nutrition, vol. 7, no. 3-4, pp. 270–276, 1998.

D. A. Vattem, Y. T. Lin, R. G. Labbe, and K. Shetty, “Phenolic antioxidant mobilization in cranberry pomace by solid-state bioprocessing using food grade fungus Lentinus edodes and effect on antimicrobial activity against selected food borne pathogens,” Innovative Food Science and Emerging Technologies, vol. 5, pp. 81–91, 2004.